Tejas Patil Jose M Pacheco Anastasios Dimou William T Purcell Candice Rossi Paul A Bunn Robert C Doebele D Ross Camidge Lisa Ferrigno
10.3389/fonc.2020.00510
Front Oncol
2020 Apr 15;10:510.
egfr nsclc osimertinib tyrosine kinase inhibitor volvulus
CC BY
https://pubmed.ncbi.nlm.nih.gov/32351892/
Case Reports
PMC7174901
32351892
Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer
2020